Signalling inhibition by ponatinib disrupts productive alternative lengthening of telomeres (ALT)
Related Posts
Waggoner T, Garcia S, Chakravarty T, Makar M, Latib A, Kipperman RM, Zahr F, Hanson I, Sinha AK, Sharma RP, Depta JP, Castellanos JA, Kodali[...]
Min JH, Chen PJ, Qureshi TA, Javed S, Xie Y, Azab L, Wang L, Kim HS, Li D, Yang JD. Prediction of Immunotherapy Response in[...]
Huang LT, Zhang X, Li X, Malagi A, Huang Y, Guan X, Ho H, Kwan A, Wei J, Bi X, Christodoulou AG, Li D, Han[...]